Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)

Taiwan · Delayed Price · Currency is TWD

72.20

+0.40 (0.56%)

May 29, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology (Startups)	36.45M	32.04M	18.92M	1.14M	1.14M
Biotechnology (Startups) Growth	13.75%	69.39%	1554.86%	0%	37.21%
Total	36.45M	32.04M	18.92M	1.14M	1.14M
Total Growth	13.75%	69.39%	1554.86%	0%	37.21%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Hong Kong and Mainland China	35.07M	31.93M	18.92M	-	-
Hong Kong and Mainland China Growth	9.84%	68.80%	-	-	-
Taiwan	1.38M	-	-	1.14M	1.14M
Taiwan Growth	-	-	-	0%	37.21%
Singapore	-	112.00K	-	-	-
Total	36.45M	32.04M	18.92M	1.14M	1.14M
Total Growth	13.75%	69.39%	1554.86%	0%	37.21%

Source: S&P Global Market Intelligence.